Firering Strategic Minerals: From explorer to producer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ten year trend keeping its direction!
Yup. Sell out
Buy back
meanwhile back in the real world of medical CT/CZT sales -
https://www.fiercebiotech.com/medtech/ge-healthcare-revenues-expand-supply-chain-issues-ease
"In its first-quarter earnings report, ultrasound brought in $859 million in revenue, up 5% as the company was able to improve on its backlog as supply chain issues eased. MRI machines, CT scanners and X-ray hardware, meanwhile, raked up $2.5 billion, for an 8% gain. Finally, patient care and monitoring solutions reported a 9% sales increase to $781 million for the quarter."
As a shareholder i have to say with regret there just are not enough idiots out there to believe the promises that are being spouted from Kromek.
Great technology on the cusp of monetising the years of development. 30p in a year a distinct possibility.Some value the company at 27p now.......what will the value be in 12 months.....when the orders pile in?.....
pedro you could have said that anytime since 2018. Look at the sp.. How many times do we get promises from Durham. Very few people left who see anything more than Smoke and Mirrors.
Mike.
As usual you point out the fantastic potential for KMK with your notes, which I agree with and why I first bought in.
The second part then is where will KMK be on this opportunity in 2,5 years time through strategic and operational excellence and execution between a 0% to 100% range. Based on what we have seen from KMK from this BOD and the CEO the answer is probably between 0% and 10%, which seems to be the weighting the market has put on KMK as well even with the recent RNSs.
With an average team this would be 25-50% with a corresponding share price 2 -3 x higher, with an all singing / dancing team 50-75% with a share price 5x plus where we are today. The market is simply pricing in the state of the the BOD and CEO.
On top of this we have the continued issues with really basic governance, integrity and dodgy accounts - with non execs just not doing their jobs in holding the management team to account.
Some say ...he's never been able to watch his favourite film 'King Kong' all the way thro'
because he comes out in a nasty rash and hot sweats.
Some say... he has an impressive collection of stificates, and qualifications all framed and carefully placed on his bedroom wall, all in Domestic Science.
Some say ...he has beautiful tattoos of emerald green and turquoise blue feathers on both arms and sleeps in a wardrobe on a heavily modified perch and this might be the reason he endlessly repeats himself and pecks at passers-by.
Some say he has an impressive collection of T-Shirts each with the picture of a Sedgefield roundabout on them, his favourite town after many childhood caravan camping holidays there, although he was always told he was going to the seaside, and has never really gotten over this.
But all we know ....he's called the SKID
Someday..he's allergic to the letter 'K'...and..
You what ?
I pointed out that the opportunity would be better maximised by a different and vaguely competent management team, ceo and bod.
You seem to have taken great offence to this statement of fact with some frankly infantile drivel.
A kmk employee by any chance ?
Well skid35 you could not have explained it better, to the ill informed. I put it more crudely than you but we see the same situation all too clearly. The sp despite so much good news from Kromek in the last 5 years,sadly proves us both to be correct. How lovely if we could be proved wrong and those in dreamland could see a 30p sp in the future,and maybe Accrington Stanley will win the Premier League.
A kmk employee by any chance ?
He could well be, skid. Or he gets s well park d for the cr4p blogs he keeps loading on here. One thing is for sure…… he’s been wrong all along!
Well paid
sell sell and may be back in at 5.75
The percentage Simon Thompson bounce has become smaller and smaller each quarter, until now where it is non existant.
The BOD now have nowhere to turn to increase the share price apart from their own performance. Let's see how they do.
Surely the only reason for the share price to increase that is worth having in the long term is good management and company performance. A short term IC/ST blip may be ok for short term holders but I was hoping to have a good, sound, longterm investment here. Unfortunately there has been precious little sign of that, to put it mildly, here so far.
Agreed Skid need management now to execute. The recent news could lead Kromek to be throwing out £10m to £15m EBITDA in 12-18 months with other OEMs possibly also going to on board. Only then will we see 30p etc but need signs of execution in coming months and also confirmation on funding - personally I would like to see a small debt/equity raise to give more working capital headroom in the medium term and then that’s it. If I was an OEM acquiring Kromek could well make sense.
Execute….. IMHO DYOR GLA
Strategic.
In the annual results they need to show they can manage working capital effectively.
They have so much cash tied up in the balance sheet if they can convert it they should have sufficient cash - but history of debtors / inventory write off / write down year after year after doesn't fill me with confidence.
Underneath the corrupt and amateur ceo, bod, senior team is a great company waiting to be managed by a professional team.